Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 23 contracts
Sources: Securities Purchase Agreement (SMART Global Holdings, Inc.), Stock Purchase Agreement (Voyager Therapeutics, Inc.), Stock Purchase Agreement (C4 Therapeutics, Inc.)
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 4 contracts
Sources: Share Purchase Agreement (Xenon Pharmaceuticals Inc.), Share Purchase Agreement (Xenon Pharmaceuticals Inc.), Share Purchase Agreement (Xenon Pharmaceuticals Inc.)
Mutual Conditions to Closing. The obligations of each of the Investor and the Company to consummate the Closing are is subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 2 contracts
Sources: Stock Purchase Agreement (Novartis Ag), Stock Purchase Agreement (Momenta Pharmaceuticals Inc)
Mutual Conditions to Closing. The obligations of the Investor Company on the one hand, and the Company Investor on the other hand, to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 2 contracts
Sources: Option, Collaboration and License Agreement (Conatus Pharmaceuticals Inc.), Investment Agreement (Conatus Pharmaceuticals Inc.)
Mutual Conditions to Closing. The obligations of each of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 2 contracts
Sources: Stock Purchase Agreement (SGX Pharmaceuticals, Inc.), Securities Purchase Agreement (Cell Therapeutics Inc)
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:: 8.1
Appears in 2 contracts
Sources: Collaboration and License Agreement (Neurocrine Biosciences Inc), Stock Purchase Agreement (Neurocrine Biosciences Inc)
Mutual Conditions to Closing. The obligations of the Investor Purchaser and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 1 contract
Sources: Common Stock Purchase Agreement (Applied Genetic Technologies Corp)
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the a Closing are is subject to the fulfillment as of the such Closing Date of the following conditions:
Appears in 1 contract
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the such Closing Date of the following conditions:
Appears in 1 contract
Sources: Securities Purchase Agreement (Loop Industries, Inc.)
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are is subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 1 contract
Sources: Stock Purchase Agreement (Regeneron Pharmaceuticals Inc)
Mutual Conditions to Closing. The obligations of the Investor and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date date hereof of the following conditions:
Appears in 1 contract
Sources: Share Purchase Agreement (Scholar Rock Holding Corp)
Mutual Conditions to Closing. The obligations of the Investor Purchaser and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 1 contract
Sources: Stock Purchase Agreement (SpringWorks Therapeutics, Inc.)
Mutual Conditions to Closing. The obligations of the Investor Investors and the Company to consummate the Closing are subject to the fulfillment as of the Closing Date of the following conditions:
Appears in 1 contract
Sources: Stock Purchase Agreement (Alnylam Pharmaceuticals, Inc.)